Europe Molecular Diagnostics Market (2016 - 2022)
Molecular Diagnostics is used to identify or monitor biomarkers associated with any particular diseases or conditions. This test could also help in detecting and quantifying the presence of specific bacteria and viruses. These devices help surgeons in deciding that which therapy would work best on different patients. Molecular Diagnostics detect the diseases by analyzing RNA (Ribonucleic Acid) or DNA (Deoxyribonucleic Acid) in humans. These diagnostics are mainly used for clinical testing devices that are supplied in clinics, hospitals, laboratories, and research institutes.
In Europe, Advances in Prenatal Molecular Diagnostics, Biomarkers for Immunotherapy, Advanced diagnostics for Infectious diseases, Point to care diagnostics, Cell free DNA in clinical oncology is playing vital role in the growth of molecular diagnostics market. According to the fourth conference on molecular diagnostics Europe held in 2016, it has been stated that arrays and next-gen sequencing are playing an increased role in the level of invasive technology. Also, it is contributing towards the increasing demand for DNA. In Addition, Cambridge Healthtech Institute has designed Inaugural Biomarkers for Immunotherapy. On the other side many health companies are also offering new range of products with molecular technologies. For Example: Siemens Healthcare has also launched its new product with new VERSANT® kPCR Molecular System. This product improves workflow and consolidation and allows multiple assays per sample and run. Recently, Microbix has also launched new range of products in molecular diagnostics. Hence, it could be expected that innovative technology could be leading the growth of molecular diagnostics market in Europe.
The Molecular Diagnostics Market is segmented on the basis of Product & Services, Technology, Application, End-user and Region. Based on Product & Services, the market is segmented into instruments, reagents & Kits, and software & services. Reagents & Kits is expected to gather largest share in the market due to rising demand of reagents in clinical centers and diagnostics centers. Based on Technology, market is segmented into Polymerase Chain Reaction (PCR), Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Hybridization, Microarray, DNA Sequencing and Next-Generation Sequencing.
Based on Application, the market is segmented into six types such as Infectious diseases molecular testing, Molecular oncology testing, Inherited diseases molecular testing, Identity testing, Tissue type testing and Pharmacogenetics testing. Infectious Diseases includes Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG), Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Hepatitis B, Hepatitis C, Tuberculosis (TB), Methicillin-Resistant Staphylococcus Aureus (MRSA) and other infectious diseases. On the other hand, oncology is further divided into Breast Cancer, Prostate Cancer, Colorectal Cancer and others. The infectious diseases molecular testing is mostly preferred in the hospitals and clinical centers. Based on End-User, the market is segmented into i clinics, hospitals, laboratories, and research institutes. Based on Country, market is segmented into Germany, UK, France, Russia, Spain and Italy.
The report covers the analysis of key stake holders of the Molecular Diagnostics market. Key companies profiled in the report include Abbott Laboratories, Qiagen N.V, Roche Diagnostics, Grifols, Siemens Healthcare (Siemens AG), Becton Dickinson and Company and Danaher Corporation.
In Europe, Advances in Prenatal Molecular Diagnostics, Biomarkers for Immunotherapy, Advanced diagnostics for Infectious diseases, Point to care diagnostics, Cell free DNA in clinical oncology is playing vital role in the growth of molecular diagnostics market. According to the fourth conference on molecular diagnostics Europe held in 2016, it has been stated that arrays and next-gen sequencing are playing an increased role in the level of invasive technology. Also, it is contributing towards the increasing demand for DNA. In Addition, Cambridge Healthtech Institute has designed Inaugural Biomarkers for Immunotherapy. On the other side many health companies are also offering new range of products with molecular technologies. For Example: Siemens Healthcare has also launched its new product with new VERSANT® kPCR Molecular System. This product improves workflow and consolidation and allows multiple assays per sample and run. Recently, Microbix has also launched new range of products in molecular diagnostics. Hence, it could be expected that innovative technology could be leading the growth of molecular diagnostics market in Europe.
The Molecular Diagnostics Market is segmented on the basis of Product & Services, Technology, Application, End-user and Region. Based on Product & Services, the market is segmented into instruments, reagents & Kits, and software & services. Reagents & Kits is expected to gather largest share in the market due to rising demand of reagents in clinical centers and diagnostics centers. Based on Technology, market is segmented into Polymerase Chain Reaction (PCR), Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Hybridization, Microarray, DNA Sequencing and Next-Generation Sequencing.
Based on Application, the market is segmented into six types such as Infectious diseases molecular testing, Molecular oncology testing, Inherited diseases molecular testing, Identity testing, Tissue type testing and Pharmacogenetics testing. Infectious Diseases includes Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG), Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Hepatitis B, Hepatitis C, Tuberculosis (TB), Methicillin-Resistant Staphylococcus Aureus (MRSA) and other infectious diseases. On the other hand, oncology is further divided into Breast Cancer, Prostate Cancer, Colorectal Cancer and others. The infectious diseases molecular testing is mostly preferred in the hospitals and clinical centers. Based on End-User, the market is segmented into i clinics, hospitals, laboratories, and research institutes. Based on Country, market is segmented into Germany, UK, France, Russia, Spain and Italy.
The report covers the analysis of key stake holders of the Molecular Diagnostics market. Key companies profiled in the report include Abbott Laboratories, Qiagen N.V, Roche Diagnostics, Grifols, Siemens Healthcare (Siemens AG), Becton Dickinson and Company and Danaher Corporation.
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Molecular Diagnostics Market, by Product & Services
1.4.2 Europe Molecular Diagnostics Market, by Technology
1.4.3 Europe Molecular Diagnostics Market, by Application
1.4.4 Europe Molecular Diagnostics Market, by End User
1.4.5 Europe Molecular Diagnostics Market, by Country
1.5 Methodology for the research
CHAPTER 2. EXECUTIVE SUMMARY
CHAPTER 3. MARKET OVERVIEW
3.1 Introduction
3.2 Drivers, Restraints and Opportunities
3.2.1 Market Drivers
3.2.2 Market Restraints
CHAPTER 4. EUROPE MOLECULAR DIAGNOSTICS MARKET
4.1 Europe Molecular Diagnostics Market by Product & Services
4.1.1 Europe Molecular Diagnostics Reagents & Kits Market by Country
4.1.2 Europe Molecular Diagnostics Instruments Market by Country
4.1.3 Europe Molecular Diagnostics Software & Services Market by Country
CHAPTER 5. EUROPE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY
5.1 Introduction
5.1.1 Europe Polymerase Chain Reaction Molecular Diagnostics Market by Country
5.1.2 Europe Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market by Country
5.1.3 Europe Hybridization Molecular Diagnostics Market by Country
5.1.4 Europe DNA Sequencing & Next-Generation Sequencing Molecular Diagnostics Market by Country
5.1.5 Europe Microarray Molecular Diagnostics Market by Country
5.1.6 Europe Other Technologies Market by Country
CHAPTER 6. EUROPE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION
6.1 Introduction
6.1.1 Europe Infectious Diseases Molecular Diagnostics Market by Country
6.1.2 Europe Infectious Diseases Molecular Diagnostics Market by Type
6.1.2.1 Europe Chlamydia Trachomatis & Neisseria Gonorrhea Molecular Diagnostics Market by Country
6.1.2.2 Europe Hepatitis B & Hepatitis C Molecular Diagnostics Market by Country
6.1.2.3 Europe Human Papillomavirus Molecular Diagnostics Market by Country
6.1.2.4 Europe Human Immunodeficiency Virus Molecular Diagnostics Market by Country
6.1.2.5 Europe Tuberculosis Molecular Diagnostics Market by Country
6.1.2.6 Europe Methicillin-Resistant Staphylococcus Aurous Molecular Diagnostics Market by Country
6.1.2.7 Europe Molecular Diagnostics in Other Infectious Diseases Market by Country
6.1.3 Europe Oncology Molecular Diagnostics Market by Country
6.1.4 Europe Oncology Molecular Diagnostics Market by Type
6.1.4.1 Europe Breast Cancer Molecular Diagnostics Market by Country
6.1.4.2 Europe Colorectal Cancer Molecular Diagnostics Market by Country
6.1.4.3 Europe Prostate Cancer Molecular Diagnostics Market by Country
6.1.4.4 Europe Other Cancers Molecular Diagnostics Market by Country
6.1.5 Europe Blood Screening Molecular Diagnostics Market by Country
6.1.6 Europe Genetic Tests Molecular Diagnostics Market by Country
6.1.7 Europe Microbiology Molecular Diagnostics Market by Country
6.1.8 Europe Other Applications Market by Country
CHAPTER 7. EUROPE MOLECULAR DIAGNOSTICS MARKET BY END USER
7.1 Introduction
7.1.1 Europe Molecular Diagnostics Market for Hospital & Academic Laboratories by Country
7.1.2 Europe Molecular Diagnostics Market for Reference Laboratories by Country
7.1.3 Europe Molecular Diagnostics Market for Other End Users by Country
CHAPTER 8. EUROPE MOLECULAR DIAGNOSTICS MARKET BY COUNTRY
8.1 Introduction
8.2 Germany Molecular Diagnostics Market
8.2.1 Germany Molecular Diagnostics Market by Product & Services
8.2.2 Germany Molecular Diagnostics Market by Technology
8.2.3 Germany Molecular Diagnostics Market by Application
8.2.3.1 Germany Infectious Diseases Molecular Diagnostics Market by Type
8.2.3.2 Germany Oncology Molecular Diagnostics Market by Type
8.2.4 Germany Molecular Diagnostics Market by End User
8.3 UK Molecular Diagnostics Market
8.3.1 UK Molecular Diagnostics Market by Product & Services
8.3.2 UK Molecular Diagnostics Market by Technology
8.3.3 UK Molecular Diagnostics Market by Application
8.3.3.1 UK Infectious Diseases Molecular Diagnostics Market by Type
8.3.3.2 UK Oncology Molecular Diagnostics Market by Type
8.3.4 UK Molecular Diagnostics Market by End User
8.4 France Molecular Diagnostics Market
8.4.1 France Molecular Diagnostics Market by Product & Services
8.4.2 France Molecular Diagnostics Market by Technology
8.4.3 France Molecular Diagnostics Market by Application
8.4.3.1 France Infectious Diseases Molecular Diagnostics Market by Type
8.4.3.2 France Oncology Molecular Diagnostics Market by Type
8.4.4 France Molecular Diagnostics Market by End User
8.5 Russia Molecular Diagnostics Market
8.5.1 Russia Molecular Diagnostics Market by Product & Services
8.5.2 Russia Molecular Diagnostics Market by Technology
8.5.3 Russia Molecular Diagnostics Market by Application
8.5.3.1 Russia Infectious Diseases Molecular Diagnostics Market by Type
8.5.3.2 Russia Oncology Molecular Diagnostics Market by Type
8.5.4 Russia Molecular Diagnostics Market by End User
8.6 Spain Molecular Diagnostics Market
8.6.1 Spain Molecular Diagnostics Market by Product & Services
8.6.2 Spain Molecular Diagnostics Market by Technology
8.6.3 Spain Molecular Diagnostics Market by Application
8.6.3.1 Spain Infectious Diseases Molecular Diagnostics Market by Type
8.6.3.2 Spain Oncology Molecular Diagnostics Market by Type
8.6.4 Spain Molecular Diagnostics Market by End User
8.7 Italy Molecular Diagnostics Market
8.7.1 Italy Molecular Diagnostics Market by Product & Services
8.7.2 Italy Molecular Diagnostics Market by Technology
8.7.3 Italy Molecular Diagnostics Market by Application
8.7.3.1 Italy Infectious Diseases Molecular Diagnostics Market by Type
8.7.3.2 Italy Oncology Molecular Diagnostics Market by Type
8.7.4 Italy Molecular Diagnostics Market by End User
8.8 Rest of Europe Molecular Diagnostics Market
8.8.1 Rest of Europe Molecular Diagnostics Market by Product & Services
8.8.2 Rest of Europe Molecular Diagnostics Market by Technology
8.8.3 Rest of Europe Molecular Diagnostics Market by Application
8.8.3.1 Rest of Europe Infectious Diseases Molecular Diagnostics Market by Type
8.8.3.2 Rest of Europe Oncology Molecular Diagnostics Market by Type
8.8.4 Rest of Europe Molecular Diagnostics Market by End User
CHAPTER 9. COMPANY PROFILES
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.2 Qiagen N.V.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 Roche Diagnostics
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 Grifols
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.5 Siemens Healthcare (Siemens AG)
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.6 Becton Dickinson and Company
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.7 Danaher Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Molecular Diagnostics Market, by Product & Services
1.4.2 Europe Molecular Diagnostics Market, by Technology
1.4.3 Europe Molecular Diagnostics Market, by Application
1.4.4 Europe Molecular Diagnostics Market, by End User
1.4.5 Europe Molecular Diagnostics Market, by Country
1.5 Methodology for the research
CHAPTER 2. EXECUTIVE SUMMARY
CHAPTER 3. MARKET OVERVIEW
3.1 Introduction
3.2 Drivers, Restraints and Opportunities
3.2.1 Market Drivers
3.2.2 Market Restraints
CHAPTER 4. EUROPE MOLECULAR DIAGNOSTICS MARKET
4.1 Europe Molecular Diagnostics Market by Product & Services
4.1.1 Europe Molecular Diagnostics Reagents & Kits Market by Country
4.1.2 Europe Molecular Diagnostics Instruments Market by Country
4.1.3 Europe Molecular Diagnostics Software & Services Market by Country
CHAPTER 5. EUROPE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY
5.1 Introduction
5.1.1 Europe Polymerase Chain Reaction Molecular Diagnostics Market by Country
5.1.2 Europe Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market by Country
5.1.3 Europe Hybridization Molecular Diagnostics Market by Country
5.1.4 Europe DNA Sequencing & Next-Generation Sequencing Molecular Diagnostics Market by Country
5.1.5 Europe Microarray Molecular Diagnostics Market by Country
5.1.6 Europe Other Technologies Market by Country
CHAPTER 6. EUROPE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION
6.1 Introduction
6.1.1 Europe Infectious Diseases Molecular Diagnostics Market by Country
6.1.2 Europe Infectious Diseases Molecular Diagnostics Market by Type
6.1.2.1 Europe Chlamydia Trachomatis & Neisseria Gonorrhea Molecular Diagnostics Market by Country
6.1.2.2 Europe Hepatitis B & Hepatitis C Molecular Diagnostics Market by Country
6.1.2.3 Europe Human Papillomavirus Molecular Diagnostics Market by Country
6.1.2.4 Europe Human Immunodeficiency Virus Molecular Diagnostics Market by Country
6.1.2.5 Europe Tuberculosis Molecular Diagnostics Market by Country
6.1.2.6 Europe Methicillin-Resistant Staphylococcus Aurous Molecular Diagnostics Market by Country
6.1.2.7 Europe Molecular Diagnostics in Other Infectious Diseases Market by Country
6.1.3 Europe Oncology Molecular Diagnostics Market by Country
6.1.4 Europe Oncology Molecular Diagnostics Market by Type
6.1.4.1 Europe Breast Cancer Molecular Diagnostics Market by Country
6.1.4.2 Europe Colorectal Cancer Molecular Diagnostics Market by Country
6.1.4.3 Europe Prostate Cancer Molecular Diagnostics Market by Country
6.1.4.4 Europe Other Cancers Molecular Diagnostics Market by Country
6.1.5 Europe Blood Screening Molecular Diagnostics Market by Country
6.1.6 Europe Genetic Tests Molecular Diagnostics Market by Country
6.1.7 Europe Microbiology Molecular Diagnostics Market by Country
6.1.8 Europe Other Applications Market by Country
CHAPTER 7. EUROPE MOLECULAR DIAGNOSTICS MARKET BY END USER
7.1 Introduction
7.1.1 Europe Molecular Diagnostics Market for Hospital & Academic Laboratories by Country
7.1.2 Europe Molecular Diagnostics Market for Reference Laboratories by Country
7.1.3 Europe Molecular Diagnostics Market for Other End Users by Country
CHAPTER 8. EUROPE MOLECULAR DIAGNOSTICS MARKET BY COUNTRY
8.1 Introduction
8.2 Germany Molecular Diagnostics Market
8.2.1 Germany Molecular Diagnostics Market by Product & Services
8.2.2 Germany Molecular Diagnostics Market by Technology
8.2.3 Germany Molecular Diagnostics Market by Application
8.2.3.1 Germany Infectious Diseases Molecular Diagnostics Market by Type
8.2.3.2 Germany Oncology Molecular Diagnostics Market by Type
8.2.4 Germany Molecular Diagnostics Market by End User
8.3 UK Molecular Diagnostics Market
8.3.1 UK Molecular Diagnostics Market by Product & Services
8.3.2 UK Molecular Diagnostics Market by Technology
8.3.3 UK Molecular Diagnostics Market by Application
8.3.3.1 UK Infectious Diseases Molecular Diagnostics Market by Type
8.3.3.2 UK Oncology Molecular Diagnostics Market by Type
8.3.4 UK Molecular Diagnostics Market by End User
8.4 France Molecular Diagnostics Market
8.4.1 France Molecular Diagnostics Market by Product & Services
8.4.2 France Molecular Diagnostics Market by Technology
8.4.3 France Molecular Diagnostics Market by Application
8.4.3.1 France Infectious Diseases Molecular Diagnostics Market by Type
8.4.3.2 France Oncology Molecular Diagnostics Market by Type
8.4.4 France Molecular Diagnostics Market by End User
8.5 Russia Molecular Diagnostics Market
8.5.1 Russia Molecular Diagnostics Market by Product & Services
8.5.2 Russia Molecular Diagnostics Market by Technology
8.5.3 Russia Molecular Diagnostics Market by Application
8.5.3.1 Russia Infectious Diseases Molecular Diagnostics Market by Type
8.5.3.2 Russia Oncology Molecular Diagnostics Market by Type
8.5.4 Russia Molecular Diagnostics Market by End User
8.6 Spain Molecular Diagnostics Market
8.6.1 Spain Molecular Diagnostics Market by Product & Services
8.6.2 Spain Molecular Diagnostics Market by Technology
8.6.3 Spain Molecular Diagnostics Market by Application
8.6.3.1 Spain Infectious Diseases Molecular Diagnostics Market by Type
8.6.3.2 Spain Oncology Molecular Diagnostics Market by Type
8.6.4 Spain Molecular Diagnostics Market by End User
8.7 Italy Molecular Diagnostics Market
8.7.1 Italy Molecular Diagnostics Market by Product & Services
8.7.2 Italy Molecular Diagnostics Market by Technology
8.7.3 Italy Molecular Diagnostics Market by Application
8.7.3.1 Italy Infectious Diseases Molecular Diagnostics Market by Type
8.7.3.2 Italy Oncology Molecular Diagnostics Market by Type
8.7.4 Italy Molecular Diagnostics Market by End User
8.8 Rest of Europe Molecular Diagnostics Market
8.8.1 Rest of Europe Molecular Diagnostics Market by Product & Services
8.8.2 Rest of Europe Molecular Diagnostics Market by Technology
8.8.3 Rest of Europe Molecular Diagnostics Market by Application
8.8.3.1 Rest of Europe Infectious Diseases Molecular Diagnostics Market by Type
8.8.3.2 Rest of Europe Oncology Molecular Diagnostics Market by Type
8.8.4 Rest of Europe Molecular Diagnostics Market by End User
CHAPTER 9. COMPANY PROFILES
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.2 Qiagen N.V.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 Roche Diagnostics
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 Grifols
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.5 Siemens Healthcare (Siemens AG)
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.6 Becton Dickinson and Company
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.7 Danaher Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
LIST OF TABLES
TABLE 1 EUROPE MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 2 EUROPE MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 3 EUROPE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 4 EUROPE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 5 EUROPE MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 6 EUROPE MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 7 EUROPE MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 8 EUROPE MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 9 EUROPE MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 10 EUROPE MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 11 EUROPE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 12 EUROPE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 13 EUROPE POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 14 EUROPE POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 15 EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 16 EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 17 EUROPE HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 18 EUROPE HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 19 EUROPE DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 20 EUROPE DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 21 EUROPE MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 22 EUROPE MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 23 EUROPE OTHER TECHNOLOGIES MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 24 EUROPE OTHER TECHNOLOGIES MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 25 EUROPE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 26 EUROPE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 27 EUROPE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 28 EUROPE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 29 EUROPE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 30 EUROPE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 31 EUROPE CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 32 EUROPE CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 33 EUROPE HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 34 EUROPE HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 35 EUROPE HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 36 EUROPE HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 37 EUROPE HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 38 EUROPE HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 39 EUROPE TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 40 EUROPE TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 41 EUROPE METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 42 EUROPE METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 43 EUROPE MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 44 EUROPE MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 45 EUROPE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 46 EUROPE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 47 EUROPE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 48 EUROPE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 49 EUROPE BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 50 EUROPE BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 51 EUROPE COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 52 EUROPE COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 53 EUROPE PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 54 EUROPE PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 55 EUROPE OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 56 EUROPE OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 57 EUROPE BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 58 EUROPE BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 59 EUROPE GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 60 EUROPE GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 61 EUROPE MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 62 EUROPE MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 63 EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 64 EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 65 EUROPE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 66 EUROPE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 67 EUROPE MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 68 EUROPE MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 69 EUROPE MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 70 EUROPE MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 71 EUROPE MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 72 EUROPE MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 73 EUROPE MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 74 EUROPE MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 75 GERMANY MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 76 GERMANY MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 77 GERMANY MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 78 GERMANY MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 79 GERMANY MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 80 GERMANY MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 81 GERMANY MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 82 GERMANY MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 83 GERMANY INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 84 GERMANY INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 85 GERMANY ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 86 GERMANY ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 87 GERMANY MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 88 GERMANY MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 89 UK MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 90 UK MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 91 UK MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 92 UK MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 93 UK MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 94 UK MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 95 UK MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 96 UK MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 97 UK INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 98 UK INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 99 UK ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 100 UK ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 101 UK MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 102 UK MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 103 FRANCE MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 104 FRANCE MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 105 FRANCE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 106 FRANCE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 107 FRANCE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 108 FRANCE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 109 FRANCE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 110 FRANCE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 111 FRANCE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 112 FRANCE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 113 FRANCE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 114 FRANCE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 115 FRANCE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 116 FRANCE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 117 RUSSIA MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 118 RUSSIA MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 119 RUSSIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 120 RUSSIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 121 RUSSIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 122 RUSSIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 123 RUSSIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 124 RUSSIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 125 RUSSIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 126 RUSSIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 127 RUSSIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 128 RUSSIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 129 RUSSIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 130 RUSSIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 131 SPAIN MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 132 SPAIN MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 133 SPAIN MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 134 SPAIN MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 135 SPAIN MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 136 SPAIN MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 137 SPAIN MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 138 SPAIN MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 139 SPAIN INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 140 SPAIN INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 141 SPAIN ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 142 SPAIN ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 143 SPAIN MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 144 SPAIN MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 145 ITALY MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 146 ITALY MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 147 ITALY MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 148 ITALY MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 149 ITALY MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 150 ITALY MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 151 ITALY MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 152 ITALY MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 153 ITALY INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 154 ITALY INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 155 ITALY ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 156 ITALY ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 157 ITALY MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 158 ITALY MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 159 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 160 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 161 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 162 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 163 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 164 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 165 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 166 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 167 REST OF EUROPE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 168 REST OF EUROPE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 169 REST OF EUROPE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 170 REST OF EUROPE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 171 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 172 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 173 KEY INFORMATION – ABBOTT LABORATORIES.
TABLE 174 KEY INFORMATION – QUIAGEN N.V.
TABLE 175 KEY INFORMATION – ROCHE DIAGNOSTIC
TABLE 176 KEY INFORMATION – GRIFOLS
TABLE 177 KEY INFORMATION – SIEMENS HEALTHCARE (SIEMENS AG)
TABLE 178 KEY INFORMATION – BECTON DICKINSON AND COMPANY
TABLE 179 KEY INFORMATION – DANAHER CORPORATION
TABLE 1 EUROPE MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 2 EUROPE MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 3 EUROPE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 4 EUROPE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 5 EUROPE MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 6 EUROPE MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 7 EUROPE MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 8 EUROPE MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 9 EUROPE MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 10 EUROPE MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 11 EUROPE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 12 EUROPE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 13 EUROPE POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 14 EUROPE POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 15 EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 16 EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 17 EUROPE HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 18 EUROPE HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 19 EUROPE DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 20 EUROPE DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 21 EUROPE MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 22 EUROPE MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 23 EUROPE OTHER TECHNOLOGIES MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 24 EUROPE OTHER TECHNOLOGIES MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 25 EUROPE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 26 EUROPE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 27 EUROPE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 28 EUROPE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 29 EUROPE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 30 EUROPE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 31 EUROPE CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 32 EUROPE CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 33 EUROPE HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 34 EUROPE HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 35 EUROPE HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 36 EUROPE HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 37 EUROPE HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 38 EUROPE HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 39 EUROPE TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 40 EUROPE TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 41 EUROPE METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 42 EUROPE METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 43 EUROPE MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 44 EUROPE MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 45 EUROPE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 46 EUROPE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 47 EUROPE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 48 EUROPE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 49 EUROPE BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 50 EUROPE BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 51 EUROPE COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 52 EUROPE COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 53 EUROPE PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 54 EUROPE PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 55 EUROPE OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 56 EUROPE OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 57 EUROPE BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 58 EUROPE BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 59 EUROPE GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 60 EUROPE GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 61 EUROPE MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 62 EUROPE MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 63 EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 64 EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 65 EUROPE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 66 EUROPE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 67 EUROPE MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 68 EUROPE MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 69 EUROPE MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 70 EUROPE MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 71 EUROPE MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 72 EUROPE MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 73 EUROPE MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 74 EUROPE MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 75 GERMANY MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 76 GERMANY MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 77 GERMANY MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 78 GERMANY MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 79 GERMANY MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 80 GERMANY MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 81 GERMANY MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 82 GERMANY MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 83 GERMANY INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 84 GERMANY INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 85 GERMANY ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 86 GERMANY ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 87 GERMANY MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 88 GERMANY MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 89 UK MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 90 UK MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 91 UK MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 92 UK MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 93 UK MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 94 UK MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 95 UK MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 96 UK MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 97 UK INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 98 UK INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 99 UK ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 100 UK ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 101 UK MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 102 UK MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 103 FRANCE MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 104 FRANCE MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 105 FRANCE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 106 FRANCE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 107 FRANCE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 108 FRANCE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 109 FRANCE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 110 FRANCE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 111 FRANCE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 112 FRANCE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 113 FRANCE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 114 FRANCE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 115 FRANCE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 116 FRANCE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 117 RUSSIA MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 118 RUSSIA MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 119 RUSSIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 120 RUSSIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 121 RUSSIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 122 RUSSIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 123 RUSSIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 124 RUSSIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 125 RUSSIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 126 RUSSIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 127 RUSSIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 128 RUSSIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 129 RUSSIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 130 RUSSIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 131 SPAIN MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 132 SPAIN MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 133 SPAIN MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 134 SPAIN MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 135 SPAIN MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 136 SPAIN MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 137 SPAIN MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 138 SPAIN MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 139 SPAIN INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 140 SPAIN INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 141 SPAIN ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 142 SPAIN ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 143 SPAIN MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 144 SPAIN MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 145 ITALY MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 146 ITALY MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 147 ITALY MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 148 ITALY MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 149 ITALY MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 150 ITALY MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 151 ITALY MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 152 ITALY MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 153 ITALY INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 154 ITALY INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 155 ITALY ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 156 ITALY ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 157 ITALY MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 158 ITALY MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 159 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 160 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 161 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 162 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 163 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 164 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 165 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 166 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 167 REST OF EUROPE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 168 REST OF EUROPE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 169 REST OF EUROPE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 170 REST OF EUROPE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 171 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 172 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 173 KEY INFORMATION – ABBOTT LABORATORIES.
TABLE 174 KEY INFORMATION – QUIAGEN N.V.
TABLE 175 KEY INFORMATION – ROCHE DIAGNOSTIC
TABLE 176 KEY INFORMATION – GRIFOLS
TABLE 177 KEY INFORMATION – SIEMENS HEALTHCARE (SIEMENS AG)
TABLE 178 KEY INFORMATION – BECTON DICKINSON AND COMPANY
TABLE 179 KEY INFORMATION – DANAHER CORPORATION
